2.88
price up icon3.97%   0.11
pre-market  Pre-market:  3.02   0.14   +4.86%
loading
Orchestra Biomed Holdings Inc stock is traded at $2.88, with a volume of 116.08K. It is up +3.97% in the last 24 hours and down -8.86% over the past month. Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$2.77
Open:
$2.81
24h Volume:
116.08K
Relative Volume:
0.30
Market Cap:
$127.96M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-1.92
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
-6.80%
1M Performance:
-8.86%
6M Performance:
-46.47%
1Y Performance:
-61.29%
1-Day Range:
Value
$2.79
$2.915
1-Week Range:
Value
$2.60
$3.29
52-Week Range:
Value
$2.37
$8.8699

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name
Name
Orchestra Biomed Holdings Inc
Name
Phone
646-343-9298
Name
Address
150 UNION SQUARE DRIVE, NEW HOPE
Name
Employee
70
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
OBIO's Discussions on Twitter

Compare OBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OBIO
Orchestra Biomed Holdings Inc
2.88 127.96M 2.76M -49.12M -46.21M -1.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-20-25 Initiated BTIG Research Buy
Jan-02-25 Initiated Barclays Overweight
Aug-22-24 Initiated H.C. Wainwright Buy
Jul-25-24 Initiated B. Riley Securities Buy
Jan-19-24 Initiated Jefferies Buy
Feb-24-23 Initiated Piper Sandler Overweight
Feb-07-23 Initiated Chardan Capital Markets Buy
View All

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

pulisher
Jun 18, 2025

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire

Jun 18, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

(OBIO) Trading Advice - news.stocktradersdaily.com

Jun 11, 2025
pulisher
Jun 02, 2025

Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks

Jun 02, 2025
pulisher
May 30, 2025

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World

May 30, 2025
pulisher
May 28, 2025

Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha

May 28, 2025
pulisher
May 21, 2025

Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN

May 21, 2025
pulisher
May 19, 2025

How To Trade (OBIO) - news.stocktradersdaily.com

May 19, 2025
pulisher
May 19, 2025

The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 15, 2025

Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation - MSN

May 15, 2025
pulisher
May 14, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Targ - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Barclays PLC Boosts Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025
pulisher
May 14, 2025

Wells Fargo & Company MN Buys 3,992 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025
pulisher
May 14, 2025

Orchestra BioMed HoldingsBreakthrough Device Designation Gives Speculative Optimism - Seeking Alpha

May 14, 2025
pulisher
May 13, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Target | OBIO Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Orchestra BioMed (OBIO) Surpasses Revenue Estimates with Strong Q1 Growth | OBIO Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy and IDE Approval for Virtue SAB Trial - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial - GlobeNewswire

May 12, 2025
pulisher
May 09, 2025

4 No-Brainer Stocks to Buy Right Now - The Globe and Mail

May 09, 2025
pulisher
May 09, 2025

(OBIO) On The My Stocks Page - news.stocktradersdaily.com

May 09, 2025
pulisher
May 08, 2025

Orchestra BioMed receives FDA approval to initiate Virtue Trial - Med-Tech Insights

May 08, 2025
pulisher
May 08, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Price T Rowe Associates Inc. MD - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

RTW INVESTMENTS, LP Increases Stake in Orchestra BioMed Holdings Inc - GuruFocus

May 08, 2025
pulisher
May 07, 2025

ORCHESTRA BIOMED Earnings Preview: Recent $OBIO Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed (OBIO) Expands Patent Portfolio for AVIM Therap - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed Expands Patent Portfolio with 10 New Patents for Hypertension Treatment, Totaling 120 Global Patents - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - MSN

May 07, 2025
pulisher
May 06, 2025

BlackRock, Inc. Reduces Stake in Orchestra BioMed Holdings Inc. - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Orchestra BioMed (NASDAQ:OBIO) Price Target Lowered to $12.00 at Barclays - Defense World

May 06, 2025
pulisher
May 06, 2025

Orchestra BioMed Holdings (OBIO) Target Price Adjustment by Barc - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Barclays Adjusts Price Target for Orchestra BioMed (OBIO) | OBIO Stock News - GuruFocus

May 05, 2025
pulisher
May 04, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by JPMorgan Chase & Co. - Defense World

May 04, 2025
pulisher
May 01, 2025

OBIO: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

How did Orchestra BioMed Holdings Inc (OBIO) fare last session? - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MyChesCo

May 01, 2025
pulisher
May 01, 2025

Orchestra Biomed sees $149,201 stock purchase by RTW Investments By Investing.com - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed Holdings Inc [OBIO] Records 200-Day SMA of $5.25 - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MyChesCo

May 01, 2025

Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Cap:     |  Volume (24h):